Back to Journals » Clinical Interventions in Aging » Volume 15

Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]

Authors Yilmaz O, Bahat G

Received 12 May 2020

Accepted for publication 26 May 2020

Published 10 June 2020 Volume 2020:15 Pages 877—878

DOI https://doi.org/10.2147/CIA.S262334

Checked for plagiarism Yes

Editor who approved publication: Dr Richard Walker


Ozlem Yilmaz, Gulistan Bahat

Department of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Istanbul 34093, Turkey

Correspondence: Ozlem Yilmaz
Department of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Topkapı Mahallesi, Turgut Özal Caddesi̇ No: 118, Istanbul 34093, Turkey
Tel +90 212 414 20 00- 31478, 33090
Fax +90 212 414 22 48
Email dr.ozlemyilmaz@hotmail.com


We have read the study of Zasadzka et al entitled “Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia” with great interest. 1 In this paper, the authors reported their study on Polish validation of the SARC-F questionnaire and reported it as a reliable tool for the assessment of sarcopenia in older adults. 
 
As authors noted, SARC-F has originally been developed in English. As it stands as one of the best tools to evaluate sarcopenia in every day practice, considering the variety of languages across Europe, the European Union Geriatric Medicine Society (EuGMS) special interest group on sarcopenia  coordinated a study to promote the cross-cultural adaptation, validation and consequent use of SARC-F. We published a methodological report paper to explain the details of the final consensus methodology. 2 In accordance with this aim, we are glad to see that Polish validation of SARC-F tool has been reported by the authors. However, we see that there are some problematic points in the article which should be clarified to help readers.
 
View the original paper by Zasadzka and colleague
A Response to Letter has been published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]